Evidence map›Paper›PMID 26549943›Full record

ReviewMediators of inflammation2015

HSP90 and HSP70: Implication in Inflammation Processes and Therapeutic Approaches for Myeloproliferative Neoplasms.

Margaux Sevin, François Girodon, Carmen Garrido, Aurélie de Thonel

Open access · goldAbstract readReview
In one paragraph

Review in Mediators of inflammation, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 42 papers.

0numbers the graph read from it
0cells of the map it votes in
42citing papers in PubMed
3.0field-weighted citation impact, top 8% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

42 citing papers in PubMed, 88 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Review
  5. Article
  6. Article
  7. Exploring the Anticancer Potential ofPlants (Basel, Switzerland) · 2023
    Article
  8. Article
  9. Article
  10. Article
  11. HSP70: an alarmin that does not induce high rates of preterm birth but does cause adverse neonatal outcomes.The journal of maternal-fetal & neonatal medicine : the official journal of the European Association of Perinatal Medicine, the Federation of Asia and Oceania Perinatal Societies, the International Society of Perinatal Obstetricians · 2021
    Article
  12. Novel Therapies in Myeloproliferative Neoplasms: Beyond JAK Inhibitor Monotherapy.Journal of immunotherapy and precision oncology · 2021
    Review
  13. Life (Basel, Switzerland) · 2021
    Article
  14. Review
  15. Article
  16. Review
  17. Article
  18. Article
  19. Global Proteomic Profiling ofMicroorganisms · 2020
    Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 2 institutions in 2 countries.

Margaux SevinINSERM, UMR 866, Equipe Labellisée Ligue contre le Cancer and Association pour la Recherche contre le Cancer, La Ligue Nationale contre le Cancer, Laboratoire d'Excellence LipSTIC, 21000 Dijon, France ; Faculty of Medicine and Pharmacy, University of Burgundy, 21000 Dijon, France.
François GirodonINSERM, UMR 866, Equipe Labellisée Ligue contre le Cancer and Association pour la Recherche contre le Cancer, La Ligue Nationale contre le Cancer, Laboratoire d'Excellence LipSTIC, 21000 Dijon, France ; Faculty of Medicine and Pharmacy, University of Burgundy, 21000 Dijon, France ; Service d'Hématologie Biologique, Pôle Biologie, 21000 Dijon, France.
Carmen GarridoINSERM, UMR 866, Equipe Labellisée Ligue contre le Cancer and Association pour la Recherche contre le Cancer, La Ligue Nationale contre le Cancer, Laboratoire d'Excellence LipSTIC, 21000 Dijon, France ; Faculty of Medicine and Pharmacy, University of Burgundy, 21000 Dijon, France ; Centre Anticancéreux Georges-François Leclerc, CGFL, 21000 Dijon, France.
Aurélie de ThonelINSERM, UMR 866, Equipe Labellisée Ligue contre le Cancer and Association pour la Recherche contre le Cancer, La Ligue Nationale contre le Cancer, Laboratoire d'Excellence LipSTIC, 21000 Dijon, France ; Faculty of Medicine and Pharmacy, University of Burgundy, 21000 Dijon, France.
La Ligue Contre le Cancer · FRUniversité de Bourgogne · FR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Myeloproliferative neoplasms (MPN) are clonal stem cell disorders that lead to the excessive production of one or more blood cell lineages. It has been reported that, in most MPN, inflammatory cytokines are frequently increased, indicating that inflammation plays a crucial role in these disorders. Heat shock proteins (HSP) are induced in response to many stressful conditions from heat shock to hypoxia and inflammation. Besides their chaperone and cytoprotective functions, HSPs are key players during inflammation, hence the term "chaperokine." Through their chaperone activity, HSP90, a stabilizer of many oncogenes (e.g., JAK2), and HSP70, a powerful antiapoptotic chaperone, tightly regulate Nuclear Factor-kappa B signalling, a critical pathway in mediating inflammatory responses. In light of this potential, several HSP90 inhibitors have been generated as anticancer agents able to degrade oncogenes. As it turns out, however, these drugs are also potent inhibitors of the inflammatory response in various diseases. Given the chaperone potential of HSP70 and the fact that HSP90 inhibitors induce HSP70, interest in HSP70 inhibitors is also increasing. Here, we focus on the implication of HSP90 and HSP70 in inflammatory responses and on the emergence of new therapeutic approaches in MPN based on HSP inhibitors.

Indexed as

HSP70 Heat-Shock ProteinsHSP90 Heat-Shock ProteinsHumansInflammation MediatorsModels, BiologicalMolecular Targeted TherapyMyeloproliferative DisordersSignal TransductionHSP70 Heat-Shock ProteinsHSP90 Heat-Shock ProteinsInflammation Mediators

Identifiers

PMID26549943
PMCPMC4624912
OpenAlexW2106902869

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.